In a busy second week of the 2026 legislative short session, here's what some state officials and lawmakers have been up to.

The Board Mandate Problem: what happens when AI pressure comes from the top down and how to actually improve adoption in your ...

NRx has received a positive review letter (Discipline Review Letter) addressing Drug Quality requesting only “Minor” administrative changesNRx ...

The 2027 C400 EV uses two electric motors that combine to produce 482 hp and 590 lb.-ft. of torque. They are powered by a ...

The FDA has approved the first generic version of Farxiga, a medication used to help control blood sugar in adults with Type 2 diabetes. The drug also helps reduce the risk of hospitalization in ...

As Asia grappled with the impact of the Iran war, a major pharmaceutical milestone quietly made the headlines. On March 20, the patent for semaglutide, the active ingredient in Novo Nordisk’s Ozempic ...

TORONTO - Anne Welch worked a physically demanding job at her local SPCA — lifting pets, cleaning kennels and walking dogs — until she retired at age 71. With the loss of that physical activity, ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

Generic versions of Novo Nordisk A/S’s hit shots Ozempic and Wegovy could be sold for under $3 a month, a new study showed, underscoring their potential to unlock global access to powerful weight-loss ...

The FDA has approved a generic drug for a rare genetic disorder. It's called Leucovorin and can be used to treat a brain disorder that limits the delivery of folate, a form of vitamin B, in the body.